A pilot study of gut microbiome modulation to enable efficacy of neoadjuvant checkpoint-based immunotherapy (IO) following chemotherapy in pancreatic ductal adenocarcinoma (PDAC).

Abstract

TPS759

Document Details

Document Type
Pub Defense Publication
Publication Date
Feb 01, 2023
Source ID
10.1200/jco.2023.41.4_suppl.tps759

Entities

People

  • Celina Ang
  • Deepak Saxena
  • Deirdre Jill Cohen
  • John P. Mandeli
  • Linda Wu
  • Max W. Sung
  • Myron E. Schwartz
  • Noah A Cohen
  • Peter Kozuch
  • Sirish Dharmapuri
  • Sofya Pintova

Organizations

  • Icahn School of Medicine at Mount Sinai
  • New York University
  • United States Department of Defense

Tags

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech